Kristy R Winkler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kristy R Winkler has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Digby Francis Warner
Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, South Africa
1 shared publication - Elmar Kirches
Institute of Neuropathology, Otto-von-Guericke University, Leipziger Str. 44, 39120 Magdeburg, Germany
1 shared publication H. Feistner
Klinik für Neurologie II
1 shared publicationI. Plate
Institut für Rechtsmedizin, Universität Magdeburg, Magdeburg, and
1 shared publicationK. Dietzmann
Institut for Neuropathologie
1 shared publicationM. Michael
Institut für Rechtsmedizin, Universität Magdeburg, Magdeburg, and
1 shared publication
Latest Publications
- Open Access
- 6 November 2020
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
Arrayed CRISPRi and quantitative imaging describe the morphotypic landscape of essential mycobacterial genes
Mycobacterium tuberculosis possesses a large number of genes of unknown or predicted function, undermining fundamental understanding of pathogenicity and drug susceptibility. To address this challenge, we developed a high-throughput functional genomics approach combining inducible CRISPR-interference and image-based analyses of morphological features and sub-cellular chromosomal localizations in the related non-pathogen, M. smegmatis. Applying automated imaging and analysis to 263 essential gene knockdown mutants in an arrayed library, we derive robust, quantitative descriptions of bacillary morphologies consequent on gene silencing. Leveraging statistical-learning, we demonstrate that functionally related genes cluster by morphotypic similarity and that this information can be used to inform investigations of gene function. Exploiting this observation, we infer the existence of a mycobacterial restriction-modification system, and identify filamentation as a defining mycobacterial response to histidine starvation. Our results support the application of large-scale image-based analyses for mycobacterial functional genomics, simultaneously establishing the utility of this approach for drug mechanism-of-action studies.
- 6 November 2020
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
Open AccessArrayed CRISPRi and quantitative imaging describe the morphotypic landscape of essential mycobacterial genes
Mycobacterium tuberculosis possesses a large number of genes of unknown or predicted function, undermining fundamental understanding of pathogenicity and drug susceptibility. To address this challenge, we developed a high-throughput functional genomics approach combining inducible CRISPR-interference and image-based analyses of morphological features and sub-cellular chromosomal localizations in the related non-pathogen, M. smegmatis. Applying automated imaging and analysis to 263 essential gene knockdown mutants in an arrayed library, we derive robust, quantitative descriptions of bacillary morphologies consequent on gene silencing. Leveraging statistical-learning, we demonstrate that functionally related genes cluster by morphotypic similarity and that this information can be used to inform investigations of gene function. Exploiting this observation, we infer the existence of a mycobacterial restriction-modification system, and identify filamentation as a defining mycobacterial response to histidine starvation. Our results support the application of large-scale image-based analyses for mycobacterial functional genomics, simultaneously establishing the utility of this approach for drug mechanism-of-action studies.
- 1 January 1999
- Published by S. Karger AG in Pathobiology
- Vol. 67 (4) , 214-218
Mitochondrial tRNACys Mutation A5823G in a Patient with Motor Neuron Disease and Temporal Lobe Epilepsy
We discovered a new homoplasmic mutation in the mitochondrial cysteine tRNA of a 60-year-old Caucasian male suffering from asymmetrical pure lower motor neuron disease (MND) and temporal lobe epilepsy (TLE). Furthermore, titrations with Amytal, an inhibitor of NADH:CoQ oxidoreductase, revealed mild mitochondrial dysfunction in skeletal muscle tissue, which was described in patients with MND in an earlier report. The mutation was undetectable in 155 Caucasian controls of both sexes, in 40 MND patients and in 13 individuals suffering from TLE. It was, however, detected in a heteroplasmic state in the patient’s mother, who did not suffer from a neurological disorder. Since this rare mutation affected a nonconserved base position and was not observed in MND or TLE materials, its relation to disease remains unclear.
- 1 January 1999
- Published by S. Karger AG in Pathobiology
- Vol. 67 (4) , 214-218
Mitochondrial tRNACys Mutation A5823G in a Patient with Motor Neuron Disease and Temporal Lobe Epilepsy
We discovered a new homoplasmic mutation in the mitochondrial cysteine tRNA of a 60-year-old Caucasian male suffering from asymmetrical pure lower motor neuron disease (MND) and temporal lobe epilepsy (TLE). Furthermore, titrations with Amytal, an inhibitor of NADH:CoQ oxidoreductase, revealed mild mitochondrial dysfunction in skeletal muscle tissue, which was described in patients with MND in an earlier report. The mutation was undetectable in 155 Caucasian controls of both sexes, in 40 MND patients and in 13 individuals suffering from TLE. It was, however, detected in a heteroplasmic state in the patient’s mother, who did not suffer from a neurological disorder. Since this rare mutation affected a nonconserved base position and was not observed in MND or TLE materials, its relation to disease remains unclear.